- Latest available (Revised)
- Original (As made)
The Misuse of Drugs (Designation) (Amendment) (No. 2) (England, Wales and Scotland) Order 2017
You are here:
- UK Statutory Instruments
- 2017 No. 1118
- Whole Instrument
- Previous
- Next
What Version
Opening Options
More Resources
Status:
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Statutory Instruments
2017 No. 1118
Dangerous Drugs, England And Wales
Dangerous Drugs, Scotland
The Misuse of Drugs (Designation) (Amendment) (No. 2) (England, Wales and Scotland) Order 2017
Made
16th November 2017
Laid before Parliament
20th November 2017
Coming into force
27th November 2017
The Secretary of State, in exercise of the powers conferred by section 7(4) of the Misuse of Drugs Act 1971(1), and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act, makes the following Order:
Citation, commencement and extent
1.—(1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment) (No. 2) (England, Wales and Scotland) Order 2017 and comes into force on the 27th November 2017.
(2) This Order extends to England and Wales and Scotland.
Amendment to the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015
2.—(1) The Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015(2) is amended as follows.
(2) In paragraph 1(a) of Part 1 of the Schedule after “Methylnaphthidate (HDMP-28)” insert—
“N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine or MPA)”.
Ben Wallace
Minister of State
Home Office
16th November 2017
EXPLANATORY NOTE
(This note is not part of the Order)
Section 7(3) of the Misuse of Drugs Act 1971 requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under that Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015 by inserting the drug known as methiopropamine or MPA into Part 1 of the Schedule to that Order.
A full impact assessment of the effect that this instrument will have on the costs of business and the voluntary sector is available and is published with the Explanatory Memorandum alongside the instrument on www.legislation.gov.uk.
(1)
(2)
S.I. 2015/704 as amended by S.I. 2016/1124 and S.I. 2017/632.
Options/Help
Print Options
PrintThe Whole Instrument
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Opening Options
Different options to open legislation in order to view more content on screen at once
Explanatory Memorandum
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as enacted version that was used for the print copy
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Impact Assessments
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
- Why the government is proposing to intervene;
- The main options the government is considering, and which one is preferred;
- How and to what extent new policies may impact on them; and,
- The estimated costs and benefits of proposed measures.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as made version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
The data on this page is available in the alternative data formats listed:
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.